1 / 39
文档名称:

妇舒宁胶囊治疗围绝经期综合征的临床研究.pdf.pdf

格式:pdf   页数:39页
下载后只包含 1 个 PDF 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

妇舒宁胶囊治疗围绝经期综合征的临床研究.pdf.pdf

上传人:2072510724 2016/3/24 文件大小:0 KB

下载得到文件列表

妇舒宁胶囊治疗围绝经期综合征的临床研究.pdf.pdf

相关文档

文档介绍

文档介绍:分类号: 密级: 湖南中医学院、矿。 77656S 编号: 硕士学位论文论文题目:塑堡宝壁耋丝瘟旦丝丝塑筮金堑煎!堕庄壁壅学科专业: 主堕塑盘茎研究生姓名: 墨堑焦导师姓名及职称: 蕉嘤坠塾撞中文摘要目的:观察妇舒宁胶囊治疗女性围绝经期综合征(肝肾阴虚证) 的临床疗效及安全『生,为妇舒宁胶囊的临床应用提供科学依据。方法:选用40例门诊确诊为女性围绝经期综合征(肝肾阴虚证) 的患者,随机分为妇舒宁胶囊治疗组和更年灵胶囊对照组,每组2 0 例。两组分别予以妇舒宁胶囊、更年灵胶囊口服,连续用药3个月为一疗程,用药一个疗程后观察治疗前后两组患者t临床症状、内分泌变化及安全性。结果: (肝肾阴虚证)显效率45%,总有效率90%;更年灵胶囊对照组显效率20%,总有效率65%。两组-f缶床疗效经统计学处理有显著性差异(P<),治疗组优于对照组。 (P<);两组间比较治疗组优于对照组(P<)。治疗组在改善潮热方面优于对照组。 、升高E:水平,对LH水平的降低上作用不明显。:两组患者治疗后血、尿、大便常规,肝、肾功能,心电图检测均无明显异常变化,表明妇舒宁胶囊安全有效,无毒副作用。结论:妇舒宁胶囊能有效治疗女性围绝经期综合征(肝肾阴虚证),能明显改善相关临床症状,调节女性围绝经期综合征患者体内内分泌水平变,临床应用安全有效,无毒副作用。关键词:围绝经期综合征肝肾阴虚证妇舒宁胶囊 A Clinical Research about theEffect ofFu Shu Ning capsule Oil treating perimenopausal syndrome Postgraduate:Lv Yah Ru Director:Prof:You Zhao ling Hunan College ofTraditional Chinese Medicine(410007) Abstract Objective:To observe theclinicaleffectand thesafety on Fu Shu Ning capsule(FSHNC)treating female perimenopausal syndrome(deficiency ofyin between the liverand thekidney).To provide scientific bases for FSHNC’S application inclinic Method:40 cases offemale perimenopausal syndrome were divided into two groups randomly:FSHNC treatment group and Geng Nian Ling Capsule(GNLC)control group,each ofwhich contained 20 cases FSHNC group and GNAL group were given FSHNC and GNLC respectively fortaking period was three and afterthe treatment,clinical symptoms,sexual hormone and safety indicesofpatients were observed. Results: rate ofrecovery ofFSHNC was 45%,the totaleffective rate was 90%.The rateofrecovery ofGNLC was 20%,the totaleffective rate was 65%.By means of statistical analysis,there was marked difference between two groups(P().So the effect ofFSHNC was prior tothe control totalcilical scores ofthetwo groups were obviously decreased aftertheirtreatment(P<),but theeffectof FSHNC was prior tothe controlgroup(P<).The treatmental group was prior to